Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain
NCT01701167 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2012-10-04
Summary
The purpose of this study will evaluate new technologies that have been included in the new PCA-9000A PET/CT System.
Conditions
- Confirm PCA-9000A PET/CT System is Effective for Its Intended Use
Sponsors & Collaborators
-
Toshiba America Medical Systems, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-02-28
Countries
- United States
Study Locations
More Related Trials
-
Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT
NCT03519659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
NCT01089998 ·Status: COMPLETED ·Phase: PHASE1
-
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
NCT04417998 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.
NCT07319897 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT
NCT01000181 ·Status: SUSPENDED
-
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
NCT01004718 ·Status: COMPLETED ·Phase: NA
-
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
NCT06717113 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Low Dose Tomosynthesis Compared to Traditional Tomosynthesis
NCT02771444 ·Status: TERMINATED ·Phase: NA
-
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
NCT06795113 ·Status: RECRUITING
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
NCT03423407 ·Status: TERMINATED
-
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
NCT03125629 ·Status: COMPLETED ·Phase: PHASE2
-
The Performance of Multi-tracer Multimodality PET in Lymphoma
NCT05004961 ·Status: UNKNOWN
-
64Cu-LLP2A for Imaging Hematologic Malignancies
NCT06636175 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
AIMN Multicenter Study: Staging of Lymphomas Using PET/CT
NCT06179693 ·Status: COMPLETED
-
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104 ·Status: UNKNOWN
-
Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager
NCT03561324 ·Status: WITHDRAWN ·Phase: NA
-
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma
NCT02928861 ·Status: UNKNOWN ·Phase: NA
-
Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT
NCT00256490 ·Status: COMPLETED ·Phase: NA
-
Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics
NCT03094897 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
PSMA-PET Imaging for Advanced ACC/SDC
NCT03319641 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation Of MP26 Features in Adults
NCT02927327 ·Status: COMPLETED ·Phase: NA
-
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
NCT02496013 ·Status: UNKNOWN ·Phase: PHASE1
-
Biodistribution and Dosimetry of 99mTc-Duramycin
NCT05177640 ·Status: COMPLETED ·Phase: PHASE1
-
Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol
NCT07110519 ·Status: RECRUITING ·Phase: EARLY_PHASE1